What was Accelerate Diagnostics’s price range in the past 12 months?
Accelerate Diagnostics lowest share price was $0.85 and its highest was $9.19 in the past 12 months.
What is Accelerate Diagnostics’s market cap?
Currently, no data Available
When is Accelerate Diagnostics’s upcoming earnings report date?
Accelerate Diagnostics’s upcoming earnings report date is May 09, 2024 which is in 20 days.
How were Accelerate Diagnostics’s earnings last quarter?
Accelerate Diagnostics released its earnings results on Mar 28, 2024. The company reported -$0.789 earnings per share for the quarter, missing the consensus estimate of -$0.749 by -$0.04.
Accelerate Diagnostics does not currently pay dividends.
What is Accelerate Diagnostics’s EPS estimate?
Accelerate Diagnostics’s EPS estimate is -$0.54.
How many shares outstanding does Accelerate Diagnostics have?
Accelerate Diagnostics has 21,664,387 shares outstanding.
What happened to Accelerate Diagnostics’s price movement after its last earnings report?
Accelerate Diagnostics reported an EPS of -$0.789 in its last earnings report, missing expectations of -$0.749. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Accelerate Diagnostics?
Among the largest hedge funds holding Accelerate Diagnostics’s share is Oracle Investment Management Inc. It holds Accelerate Diagnostics’s shares valued at 437K.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.